Unichem Laboratories Limited

NSE:UNICHEMLAB.NS

501.2 (INR) • At close September 3, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2026 Q12025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42017 Q4
Revenue 5,2665,871.85,330.94,621.64,464.3334,317.0054,343.7874,156.294,231.8654,020.9943,024.9523,288.1933,096.0833,481.0343,113.0522,906.6082,979.1262,289.0023,262.8493,175.0833,172.6842,660.9792,970.532,956.0642,977.3523,176.2753,028.2092,611.5142,411.7032,008.53210,082.33
Cost of Revenue 2,450.52,645.71,915.21,744.82,873.9182,934.6831,664.871,628.0581,684.4121,733.4441,378.1211,295.1051,102.5971,230.3551,093.093978.4191,103.547816.5521,036.867982.8481,273.1671,128.258895.9551,046.71,023.0391,333.4131,050.5371,255.5721,033.0581,163.3823,369.64
Gross Profit 2,815.53,226.13,415.72,876.81,590.4151,382.3222,678.9172,528.2322,547.4532,287.551,646.8311,993.0881,993.4862,250.6792,019.9591,928.1891,875.5791,472.452,225.9822,192.2351,899.5171,532.7212,074.5751,909.3641,954.3131,842.8621,977.6721,355.9421,378.645845.156,712.69
Gross Profit Ratio 0.5350.5490.6410.6220.3560.320.6170.6080.6020.5690.5440.6060.6440.6470.6490.6630.630.6430.6820.690.5990.5760.6980.6460.6560.580.6530.5190.5720.4210.666
Reseach & Development Expenses 0000257.135225.752262.334290.338268.246294.799282.948295.707220.528301.473264.163252.004309.77363.235365.768266.409303.669312.715458.725394.167398.71352.43466.93410.478360.6170616.938
General & Administrative Expenses 000001,016.89000806.099000719.552000803.608000762.368000715.7010000467.376
Selling & Marketing Expenses 00000157.728000117.458000144.12200026.80900039.83500037.455000071.727
SG&A 0964.700984.8661,174.6181,054.31,183.1111,010.944923.557880.098981.353899.242863.674876.965800.795765.99830.417782.395750.341776.61802.203659.952677.615646.574753.156611.99547.702562.526512.778539.103
Other Expenses 2,908.502,865.92,586.90-1,256.225112.76555.35586.30751.107163.51492.05678.474-326.042146.58526.518157.891-372.928156.059100.405167.102-787.689250.958281.328262.623-750.834272.902316.354187.7351,470.7314,809.551
Operating Expenses 2,908.5964.72,865.92,586.91,242.0012,656.5952,576.3472,735.1482,554.9852,737.8912,376.5792,454.8452,242.8991,785.6412,198.382,086.2082,113.1871,495.4412,132.9422,104.9111,984.1351,609.7372,440.8872,387.2392,339.0021,642.7392,355.2722,056.2041,862.5281,398.0594,809.551
Operating Income -932,261.4549.8289.91,616.543-1,274.273215.335-151.56178.775-399.234-566.234-369.701-249.413462.695-178.421-158.019-237.608-22.99193.0487.324-84.618-77.016-366.312-477.875-384.689200.123-377.6-700.262-483.883-552.9091,903.139
Operating Income Ratio -0.0180.3850.1030.0630.362-0.2950.05-0.0360.019-0.099-0.187-0.112-0.0810.133-0.057-0.054-0.08-0.010.0290.028-0.027-0.029-0.123-0.162-0.1290.063-0.125-0.268-0.201-0.2750.189
Total Other Income Expenses Net 2.837.968.740-1,466.556655.004-595.766-218.822-57.612-356.665-1,070.954-10.77242.667116.65864.2912.899147.19452.587141.85992.537155.05681.421232.316262.548247.50527.165-1,016.139-800.853-761.365-842.37297.976
Income Before Tax -90.2578618.5329.9149.987-1,258.685839.683-218.82221.163-471.566-612.788-472.529-206.746579.353-114.13-155.12-90.41429.596234.899179.86170.4384.405-133.996-215.327-137.184227.288-117.387-403.091-305.86322.4812,001.115
Income Before Tax Ratio -0.0170.0980.1160.0710.034-0.2920.193-0.0530.005-0.117-0.203-0.144-0.0670.166-0.037-0.053-0.030.0130.0720.0570.0220.002-0.045-0.073-0.0460.072-0.039-0.154-0.1270.0110.198
Income Tax Expense 14.548.3402557.42934.401-0.22226.05727.846-28.91126.483234.13426.941-135.36826.918-26.95224.47433.682-0.70992.47946.094176.28811.9766.761-75.302-90.125-134.558-17.503-101.29140.679283.021
Net Income -104.7529.7578.5304.992.558-1,293.086839.905-244.879-6.683-442.655-639.271-706.663-233.687714.721-141.048-128.168-114.888-4.086235.60887.38224.344-171.883-145.972-222.088-61.882379.914-3.023-410.323-204.572-23.768290.108
Net Income Ratio -0.020.090.1090.0660.021-0.30.193-0.059-0.002-0.11-0.211-0.215-0.0750.205-0.045-0.044-0.039-0.0020.0720.0280.008-0.065-0.049-0.075-0.0210.12-0.001-0.157-0.085-0.0120.029
EPS -1.497.528.224.341.31-18.3711.93-3.48-0.095-6.29-9.08-10.04-3.3210.16-2-1.82-1.63-0.0583.351240.35-2.44-2.07-3.16-0.885.46-0.043-5.83-2.91-0.344.17
EPS Diluted -1.497.58.194.321.31-18.3711.92-3.48-0.095-6.29-9.08-10.04-3.329.99-2-1.82-1.63-0.0583.351240.35-2.44-2.07-3.16-0.885.46-0.043-5.83-2.91-0.344.17
EBITDA 293.1926.2991.4663.2434.981-941.1781,174.062142.985366.487-119.491-264.113-141.28368.82828.255140.29292.795141.476268.802457.268399.022287.876250.70879.37813.26860.46454.96473.823-229.049-154.728186.2682,130.102
EBITDA Ratio 0.0560.1580.1860.1440.097-0.2180.270.0340.087-0.03-0.087-0.0430.0220.2380.0450.0320.0470.1170.140.1260.0910.0940.0270.0040.020.1430.024-0.088-0.0640.0930.211